BIRC5 and lung adenocarcinoma: In addition, there is evidence that the expression of PLAUR is upregulated in fentinib-resistant lung adenocarcinoma cells, and PLAUR can induce gefitinib resistance in gefitinib-resistant human lung adenocarcinoma cells through the EGFR/p-AKT/survivin signaling pathway [16].